Viewing nowNeotelmi Tablet 40 mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

MFDS item code 201804331 · Approved 2018.10.31 · Insurance code 653805330
Treatment of essential hypertension, prevention of cardiovascular disease in high-risk patients
This medication effectively lowers blood pressure in patients with essential hypertension, reducing the burden on blood vessels and the heart. It is also used to decrease the risk of myocardial infarction, stroke, and mortality due to cardiovascular diseases in patients aged 55 or older who are at high risk for cardiovascular conditions. It can be used as an alternative when ACE inhibitors are not suitable. This medication helps maintain cardiovascular health and reduce the risk of complications.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4∼8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution in patients with mild to moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication may cause serious harm to the fetus and newborn during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Pregnant women or women of childbearing age, and nursing mothers should not take this medication. Patients with severely impaired liver function or problems with bile excretion should also avoid this medication. Patients with hereditary angioedema or a history of angioedema should avoid taking this drug. Patients with diabetes or moderate to severe renal impairment should not use specific medications concurrently. Elderly patients, those with hyperkalemia, and patients with mild to moderate liver impairment should use this medication with caution. Caution is required when administered to patients with valvular heart disease or cardiovascular diseases. Patients with renal artery stenosis or severe renal impairment should consult a physician before taking this medication. This drug lowers blood pressure, occasionally causing dizziness, hypotension, syncope, etc.; therefore, symptoms should be carefully monitored while taking it. Serious adverse reactions such as hyperkalemia, renal function deterioration, liver dysfunction, angioedema, interstitial pneumonia, and rhabdomyolysis may occur, and any unusual symptoms should be reported to medical personnel immediately. This medication may enhance the blood pressure-lowering effect if used with other antihypertensive agents, so it should be taken according to the physician's instructions. In particular, combinations with ACE inhibitors and aliskiren are not recommended due to potential risks. Caution is also required when taken with potassium supplements or potassium-sparing diuretics, as serum potassium levels may rise. It is advisable to discontinue this medication 24 hours before surgery. It is not recommended for children and adolescents under 18 years due to insufficient safety and efficacy established. Caution is advised while driving or operating machinery due to risks of dizziness or syncope. Overdosage may result in hypotension, tachycardia, dizziness, acute renal failure, necessitating immediate medical attention. This medication should be stored out of reach of children and should be opened only prior to use.
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it should be stored in a tightly closed container. The recommended storage temperature is a room temperature between 1 degree and 30 degrees Celsius. This helps maintain the drug's effectiveness for a longer time.
White or nearly white, biconvex round tablet
10 tablets/blister x 3, 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.